CenterBook Partners LP Purchases New Shares in Agilon Health, Inc. (NYSE:AGL)

CenterBook Partners LP acquired a new stake in Agilon Health, Inc. (NYSE:AGL - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,920,265 shares of the company's stock, valued at approximately $8,315,000. CenterBook Partners LP owned 0.46% of Agilon Health at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of Agilon Health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after acquiring an additional 272,787 shares during the period. Capital International Investors grew its stake in shares of Agilon Health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period. Millennium Management LLC grew its stake in shares of Agilon Health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares during the period. Geode Capital Management LLC grew its stake in shares of Agilon Health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock worth $13,168,000 after acquiring an additional 35,207 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Agilon Health by 8.8% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company's stock worth $21,388,000 after acquiring an additional 398,027 shares during the period.

Agilon Health Price Performance

Agilon Health stock traded down $0.04 during trading hours on Friday, reaching $2.13. The company had a trading volume of 3,065,771 shares, compared to its average volume of 5,153,708. Agilon Health, Inc. has a 12-month low of $1.50 and a 12-month high of $7.62. The firm has a market cap of $881.71 million, a price-to-earnings ratio of -3.61 and a beta of 0.16. The company has a 50-day moving average price of $2.31 and a 200 day moving average price of $3.24.

Agilon Health (NYSE:AGL - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.04. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The firm had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same period in the previous year, the firm earned ($0.02) earnings per share. The business's revenue was down 4.5% compared to the same quarter last year. As a group, research analysts expect that Agilon Health, Inc. will post -0.59 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently weighed in on AGL shares. The Goldman Sachs Group increased their price target on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research note on Thursday, May 8th. Barclays increased their price target on Agilon Health from $2.00 to $3.00 and gave the stock an "underweight" rating in a research note on Thursday, May 8th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and raised their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Finally, Wells Fargo & Company cut their target price on Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research note on Tuesday, May 13th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $4.71.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.